Biochemistry

Edited by: Steve Bunk M.P. Boldin, T.M. Goncharov, Y.V. Goltsev, D. Wallach, "Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death," Cell, 85:803-15, 1996. (Cited in more than 250 publications as of January 1998) Comments by David Wallach, Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel Photo: Mike Goldberg DIRECT ROUTE: David Wallach of the Weizmann Institute wrote a paper that he says provided the f

Written bySteve Bunk
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edited by: Steve Bunk
M.P. Boldin, T.M. Goncharov, Y.V. Goltsev, D. Wallach, "Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death," Cell, 85:803-15, 1996. (Cited in more than 250 publications as of January 1998)

Comments by David Wallach, Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel

Photo: Mike Goldberg

DIRECT ROUTE: David Wallach of the Weizmann Institute wrote a paper that he says provided the first evidence that receptors can signal through direct activation of proteases to begin apoptosis.
Cell death and signal transduction are two of the most intensive research fields in biochemistry worldwide. The work described in this paper resulted in findings significant to both those fields. In so doing, it built upon two already-established points of knowledge.

The first point was one to which the laboratory of David Wallach, a professor in the department of biological chemistry at the Weizmann ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies